Value of stent boost imaging in decision making after coronary stenting.


Journal

The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 08 05 2023
accepted: 16 09 2023
medline: 4 12 2023
pubmed: 17 10 2023
entrez: 16 10 2023
Statut: ppublish

Résumé

Several studies reported the comparability of digital stent enhancement techniques (including stent boost imaging) in detecting suboptimal results of coronary stenting with Intra Vascular Ultrasound and optical coherence tomography. to assess results of stent deployment and determine the incidence of suboptimal results requiring changing final decision using stent boost imaging. This cross-sectional study included 120 patients eligible for PCI were recruited during a period of one year (January 2021 to 2022) using DES. Suboptimal results were found in 38% of the PCI cases with stents (angiography guided). Importantly it was found that improper lesion preparation in our practice could not help improving stent optimization. Also, angiography guided PCI has significant incidence of suboptimal results. Digital stent enhancement techniques like stent boost have significant and important value in better decision making. After adjusting for age and sex, six factors were identified as independent predictors for final decision change (stent length, LAD/RCA affection, proximal segment affection, calcification, and optical coherence tomography. This study has confirmed the utility of stent boost for the optimization of PCI in daily practice. Stent Boost is a simple and costless technique that provides an accurate assessment of a deployed stent without extending the procedure time and without more risk. It appears to be useful for the immediate evaluation of stent expansion and optimization of PCI by additional post-dilatation, when appropriate. Future studies are needed to determine whether Stent Boost data will correlate with adverse long-term clinical outcomes in patients undergoing PCI.

Sections du résumé

BACKGROUND BACKGROUND
Several studies reported the comparability of digital stent enhancement techniques (including stent boost imaging) in detecting suboptimal results of coronary stenting with Intra Vascular Ultrasound and optical coherence tomography.
AIMS OBJECTIVE
to assess results of stent deployment and determine the incidence of suboptimal results requiring changing final decision using stent boost imaging.
METHODS METHODS
This cross-sectional study included 120 patients eligible for PCI were recruited during a period of one year (January 2021 to 2022) using DES.
RESULTS RESULTS
Suboptimal results were found in 38% of the PCI cases with stents (angiography guided). Importantly it was found that improper lesion preparation in our practice could not help improving stent optimization. Also, angiography guided PCI has significant incidence of suboptimal results. Digital stent enhancement techniques like stent boost have significant and important value in better decision making. After adjusting for age and sex, six factors were identified as independent predictors for final decision change (stent length, LAD/RCA affection, proximal segment affection, calcification, and optical coherence tomography.
CONCLUSION CONCLUSIONS
This study has confirmed the utility of stent boost for the optimization of PCI in daily practice. Stent Boost is a simple and costless technique that provides an accurate assessment of a deployed stent without extending the procedure time and without more risk. It appears to be useful for the immediate evaluation of stent expansion and optimization of PCI by additional post-dilatation, when appropriate. Future studies are needed to determine whether Stent Boost data will correlate with adverse long-term clinical outcomes in patients undergoing PCI.

Identifiants

pubmed: 37845408
doi: 10.1007/s10554-023-02961-4
pii: 10.1007/s10554-023-02961-4
pmc: PMC10692007
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2557-2566

Informations de copyright

© 2023. The Author(s).

Références

EuroIntervention. 2015 Apr;10(12):1409-17
pubmed: 25912391
J Interv Cardiol. 2013 Oct;26(5):444-53
pubmed: 24106743
Circulation. 1992 Mar;85(3):916-27
pubmed: 1537128
Circ Cardiovasc Interv. 2022 Jan;15(1):e011366
pubmed: 35041452
Heart Vessels. 2013 Jan;28(1):1-6
pubmed: 22038109
Egypt Heart J. 2018 Mar;70(1):21-26
pubmed: 29622993
J Am Coll Cardiol. 2005 Aug 16;46(4):575-81
pubmed: 16098418
N Engl J Med. 1991 Jan 3;324(1):13-7
pubmed: 1984159
J Am Coll Cardiol. 2014 Jun 24;63(24):2659-73
pubmed: 24632282
JAMA. 2005 Sep 14;294(10):1215-23
pubmed: 16160130
Circulation. 1997 Nov 4;96(9):2997-3005
pubmed: 9386168
Heart. 2004 Dec;90(12):1455-9
pubmed: 15547028
Circ Cardiovasc Interv. 2011 Feb 1;4(1):9-14
pubmed: 21266707
Lancet. 2016 Nov 26;388(10060):2607-2617
pubmed: 27806902
J Am Coll Cardiol. 2005 Apr 5;45(7):995-8
pubmed: 15808753
Circulation. 1999 Oct 26;100(17):1777-83
pubmed: 10534464
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
N Engl J Med. 2013 Jan 17;368(3):254-65
pubmed: 23323902
Circulation. 2004 Mar 9;109(9):1085-8
pubmed: 14993129
J Am Coll Cardiol. 2013 Jun 11;61(23):e179-347
pubmed: 23639841
BMC Cardiovasc Disord. 2022 Feb 20;22(1):62
pubmed: 35184740
Indian Heart J. 2021 Sep-Oct;73(5):660-663
pubmed: 34627590
Int Heart J. 2015;56(1):37-42
pubmed: 25742941
N Engl J Med. 1987 Mar 19;316(12):701-6
pubmed: 2950322
JACC Cardiovasc Interv. 2016 Dec 26;9(24):2493-2507
pubmed: 28007201
JACC Cardiovasc Interv. 2020 Jun 22;13(12):1403-1413
pubmed: 32473888
Eur Heart J. 2015 Aug 21;36(32):2147-59
pubmed: 25994755
Circ Cardiovasc Interv. 2016 Jul;9(7):
pubmed: 27412872

Auteurs

Hossam M Mansour (HM)

Department of Cardiology, Faculty of Medicine, Aswan University, Aswan, 81528, Egypt.

Ahmed M Mohamed (AM)

Department of Cardiology, Faculty of Medicine, Aswan University, Aswan, 81528, Egypt. ahmedmakram1.am@gmail.com.

Soliman G Ibrahim (SG)

Department of Cardiology, Faculty of Medicine, Cairo University, Cairo, Egypt.

Ayman M Ibrahim (AM)

Department of Cardiology, Faculty of Medicine, Aswan University, Aswan, 81528, Egypt.

Ramadan G Mohamed (RG)

Department of Cardiology, Faculty of Medicine, Aswan University, Aswan, 81528, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH